PetMed Express (PETS) Stock: Buy, Sell, or Hold?
PETS - PetMed Express, Inc.
$1.65
-0.05 (-2.94%)
▼
5d:
-10.81%
30d:
-17.91%
90d:
-10.33%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When PETS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PETS is down 10.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PETS is down 10.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PETS is currently trading at $1.65, which is considered oversold relative to its 30-day fair value range of $1.74 to $1.95. From a valuation perspective, the stock is trading at a discount (Forward PE: 23.6) compared to its historical average (149.1). Remarkably, the market is currently pricing in an annual earnings decline of 45.9% over the next few years. This pessimistic expectation contrasts with the company's recent 266.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PETS is in a strong downtrend. The price is currently testing key support at $1.65. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PETS scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.15 (+30.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PETS is in a strong downtrend. The price is currently testing key support at $1.65. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PETS scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.15 (+30.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.74 -
$1.95
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 30.3% below Wall St target ($2.15)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.74 -
$1.95
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.65
Resistance Level
$1.93
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.57
Wall Street Target
$2.15
(+30.3%)
Revenue Growth (YoY)
-19.9%
Earnings Growth (YoY)
266.7%
Profit Margin
-17.3%
Valuation Discount vs History
-45.9% cheaper
PE vs Historical
23.6 vs 149.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-45.9%
(market-implied from PE analysis)
1-Year Target
$1.49
(-10%)
2-Year Target
$1.34
(-19%)
3-Year Target
$1.20
(-27%)
3-Yr Target (if PE normalizes)
(PE: 24→149)
$7.61
(+361%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 23.6 to 149.1
Stabilization Target:
$10.44
(+532.5%)
PE Expansion Potential:
+532.5%
Share & Embed Analysis
Last updated: September 12, 2026 8:20 PM ET
Data refreshes hourly during market hours. Next update: 9:20 PM
Data refreshes hourly during market hours. Next update: 9:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PETS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Pharmaceutical Retailers Stocks
Top-rated stocks in Pharmaceutical Retailers by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HITI
High Tide Inc |
STRONG BUY
5 analysts |
$5 | 48 HOLD |
